Sign inJoin waitlistJoin the waitlist

Nkechi Mba

Pediatrics / Pediatric Hematology-Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
1997–2000
Pediatrics
Nassau University Medical Center
1994–1997
Doctor of Medicine
1990–1994

Research

Effect of a Daily Text Messaging and Directly Supervised Therapy Intervention on Oral Mercaptopurine Adherence in Children With Acute Lymphoblastic Leukemia: A Randomized Clinical…
JAMA Network Open · 2020 · 29 citations
Latest Update on Prevention of Acute Chemotherapy-Induced Nausea and Vomiting in Pediatric Cancer Patients
Review · Current Oncology Reports · 2019 · Last of 3 authors · 21 citations
Hematogones Detected by Flow Cytometry in a Child with Vitamin B12 Deficiency
Case report · Pediatric and Developmental Pathology · 2017 · 4 citations

Farha Sherani
3 papers
David Freyer
2 papers
Elizabeth Raetz
2 papers
Paula Aristizabal
2 papers
SC
Samanta Catueno
2 papers · 2 as a fellow
Smita Bhatia
2 papers
UB
Utpal Bhalala
2 papers
Wendy Landier
2 papers
Allan Walkey
1 paper
Aman Wadhwa
1 paper
Balagangadhar Totapally
1 paper
Catherine Boston
1 paper

Clinical trials

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2033
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2030